Everence Capital Management’s AngioDynamics ANGO Stock Holding History

Everence Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,480	Closed	-$99K	–	741
2023 Q2	$99K	Hold	10,480	–	–	0.01%	716
2023 Q1	$108	Hold	10,480	–	–	0.01%	734
2022 Q4	$144	Hold	10,480	–	–	0.01%	730
2022 Q3	$214K	Hold	10,480	–	–	0.02%	628
2022 Q2	$203K	Buy	+10,480	New	+$215K	0.02%	640
2020 Q3	–	Sell	-24,590	Closed	-$251K	–	677
2020 Q2	$251K	Buy	+24,590	New	+$253K	0.03%	507

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Everence Capital Management's ANGO Position: Q3 2023 in Review

Everence Capital Management sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 10,480 shares — an estimated $99K sold.

Everence Capital Management first reported a position in ANGO in Q2 2020 and held it in 6 quarters. The position peaked at $251K in Q2 2020. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

Everence Capital Management reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
Everence Capital Management sold 10,480 AngioDynamics shares in Q3 2023, an estimated $99K.
Everence Capital Management first reported a position in AngioDynamics in Q2 2020 and held it in 6 quarters.
Everence Capital Management's AngioDynamics position peaked at $251K in Q2 2020.
154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on Everence Capital Management's 13F filing for Q3 2023, filed 16 Oct 2023.